期刊文献+

新型冠状病毒肺炎治疗药物的研究现状及对策建议 被引量:25

Current status and countermeasures for development of drugs to treat coronavirus disease 2019
下载PDF
导出
摘要 自新型冠状病毒(SARS-CoV-2)疫情发生以来,国内外多家研究机构投入到抗新型冠状病毒肺炎(简称新冠肺炎,coronavirus disease 2019,COVID-19)的药物研发中。目前主要采取老药新用的策略,筛选抗新冠病毒和抑制过度免疫反应的候选药物,相关研究已经取得了重要进展。本文在综述已经纳入国家卫健委印发的新型冠状病毒肺炎诊疗方案中以及在体外已经证实对新型冠状病毒具有抑制作用的药物研发和临床应用的现状的基础上,对未来新冠肺炎治疗药物的研究对策提出建议:①从"老药新用"策略向创新药物研发转变;②构建可靠的体内外药物筛选模型;③建立新冠肺炎药物研发的协同创新机制;④有序开展新冠肺炎的药物临床试验;⑤建立冠状病毒研发的长效机制。 Since the outbreak of the epidemic caused by severe acute respiratory syndrome coronavirus 2(SARS-CoV-2),or 2019 novel coronavirus(2019-nCoV)provisionally,many research institutions at home and abroad have involved in the research and development(R&D)of drugs against coronavirus disease 2019(COVID-19).At present,the strategy of new use of old drugs is used to screen candidate drugs which inhibit the virus or excessive immune response,and the related researches have made important progress.This article reviewed current status of development and clinical application of those drugs which have been included in the diagnosis of novel coronavirus-infected pneumonia and treatment protocols which have been shown to inhibit the virus in vitro.In addition,we have following suggestions for future researches on the development of novel drugs against COVID-19:①from"new use of old drugs"strategy to innovative drug R&D;②building reliable models for screening drugs in vitro and in vivo;③establishing a synergistic innovation mechanism for drug R&D against COVID-19;④conducting clinical trials of the drugs in order;⑤establishing a long-term mechanism for drug R&D against COVID-19.
作者 邹全明 李海波 曾浩 ZOU Quanming;LI Haibo;ZENG Hao(Department of Microbiology and Biochemical Pharmacy,National Engineering Research Center of Immunological Products,Faculty of Pharmacy and Laboratory Medicine,Army Medical University(Third Military Medical University),Chongqing,400038,China)
出处 《第三军医大学学报》 CAS CSCD 北大核心 2020年第9期861-866,共6页 Journal of Third Military Medical University
基金 国家自然科学基金面上项目(31670936) 重庆市新型冠状病毒感染肺炎疫情应急科技攻关专项(2020)。
关键词 新型冠状病毒 新冠病毒肺炎 治疗药物 药物研发 severe acute respiratory syndrome coronavirus 2 coronavirus disease 2019 therapeutic drug drug development
  • 相关文献

参考文献1

共引文献129

同被引文献316

引证文献25

二级引证文献72

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部